Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

SOIBD Collagenous Colitis Maintenance Study (SCCMS)

This study has been completed.
Sponsor:
Collaborator:
The Swedish Organization for Studies on Inflammatory Bowel Disease
Information provided by (Responsible Party):
Dr. Falk Pharma GmbH
ClinicalTrials.gov Identifier:
NCT01278082
First received: January 14, 2011
Last updated: January 20, 2016
Last verified: January 2016